The State of Substance Use Disorder Treatment in Louisiana, Mid-2026

A season of recognition

On July 27, the Louisiana Association of Substance Abuse Counselors & Trainers (LASACT) held its 2026 Annual Awards Luncheon in Baton Rouge, where our founder, Stephen Wright, received the association's French Award — given in loving memory of Chris French, LASACT President from 2005 to 2007 — for dedication to the advancement of the field of prevention and addiction recovery. It's a fitting moment to take stock of where SUD treatment policy in Louisiana actually stands, because the honest answer is: further along in some places than others.

Reimbursement: real, measurable gains

The clearest bright spot is Medicaid reimbursement. Over the past three years, advocacy on behalf of Louisiana's addiction treatment provider community has helped secure $40.7 million in additional combined state and federal appropriations for Medicaid SUD rates — $10 million in additional State General Fund and $30.7 million in additional federal match. That funding has translated directly into fee-for-service rate increases across the ASAM continuum of care:

The largest percentage gain, a 71% increase for adult ASAM 3.1 residential care, is the kind of movement that changes staffing and capacity decisions at the facility level rather than just padding a margin. More dollars per treatment day means more room for clinical staffing, medication access, safety, and quality improvement, which is the argument providers have been making to budget writers for years.

On the regulatory side, 2024's Act 692 (HB 374) gave residential SUD treatment providers facility-need review protections, tying new capacity to demonstrated public need rather than allowing the market to oversaturate a given area. The idea is to protect access and quality simultaneously: growth follows need, not just opportunity.

Parity: progress that's stalling nationally

Louisiana Medicaid has operated under mental health parity compliance requirements since federal rules took effect in the 2010s, and the state participates in a collaborative enforcement arrangement with CMS for commercial-market parity oversight. But the national picture has gotten more complicated in the past year. The 2024 federal rule that would have strengthened parity enforcement — requiring insurers to document, not just assert, that mental health and SUD treatment limits are comparable to medical/surgical limits — is now in legal limbo. In a March 2026 court filing, the Departments of Labor, HHS, and Treasury told a federal judge they will not defend that rule, and said a replacement won't arrive until the end of 2026 at the earliest. The current administration has also declined to enforce the rule's key requirements in the meantime.

The practical effect is that states are increasingly on their own. A handful — Georgia most aggressively, with more than 6,000 logged parity violations across 22 insurers in 2025 and 2026 — have used their own enforcement authority to fill the gap. Louisiana has not moved in that direction, and with federal enforcement in retreat, the case for the state to build out independent parity enforcement capacity, rather than relying on the federal backstop, is stronger than it was a year ago.

Collaborative care: real opportunity, real gap

The Psychiatric Collaborative Care Model — team-based integration of behavioral health into primary care, billed to Medicaid and Medicare under a set of CPT codes — has grown rapidly nationally, with use up 26-fold among commercially insured patients between 2018 and 2024. Louisiana is not part of that growth story yet. National data published this year put Louisiana among the lowest-adoption states, with fewer than 50 CoCM patients per 100,000 eligible individuals, compared with over 1,000 in leading states like Arizona and Wisconsin.

That gap is a reimbursement and workforce story more than a demand story. States with the strongest CoCM uptake generally have both clear Medicaid billing pathways and rates that don't trail Medicare by much; states with weak uptake tend to have neither. For SUD-adjacent behavioral health providers looking at integration with primary care as a growth strategy, this is one of the more consequential gaps in Louisiana's current system, and one of the more addressable ones.

Telehealth: steady, incremental progress

Telehealth has been a quieter but consistent area of advancement. Louisiana's telehealth parity statute requires that covered services delivered via telehealth be reimbursed comparably to in-person care, and recent legislative and regulatory activity has kept extending that principle into new corners of practice — including a 2025 law guaranteeing telehealth coverage and reimbursement parity for occupational therapy, and continued updates to LDH's Behavioral Health Services manual (most recently reissued in February 2026) governing telehealth delivery of behavioral health and SUD services under Medicaid. The state's approach has generally avoided the restrictive posture some other states take on originating-site or platform requirements, which has kept telehealth viable as a real access tool for rural SUD treatment rather than a pandemic-era exception that quietly narrows over time.

What moved (and didn't) in the 2026 Regular Session

The Legislature took up several SUD-specific measures this year, with mixed and sometimes contradictory results:

• HB 676 (Rep. Spell) — "body brokering." Signed into law May 22, this creates a new crime for fraudulent patient referrals: soliciting, paying, or receiving kickbacks for referring a patient to a residential substance abuse facility, mental health facility, or licensed SUD treatment provider. Penalties run up to five years imprisonment and a $50,000 fine, with restitution to victims. This closes a gap that's plagued the treatment industry nationally as patient-brokering schemes have followed insurance dollars into vulnerable communities.

• SB 43 (Sen. McMath) — Psychedelic-Assisted Therapy Initiative. Passed both chambers unanimously and effective August 1, this establishes a state framework within LDH's Office of Behavioral Health to support academic clinical research into ibogaine, psilocybin, and other psychedelic-assisted therapies for opioid use disorder and co-occurring substance use disorders, with parishes able to direct opioid settlement funds toward enrolling eligible participants in approved studies. It doesn't legalize anything, but it positions Louisiana to participate in what's becoming a genuinely active national research push.

• SB 26 (Sen. McMath) — opioid treatment program facility-need review repeal. This passed the Senate 37-0 and would repeal the facility-need review requirement specifically for opioid treatment programs, the opposite regulatory direction from the residential facility-need review protections established in 2024. It's worth watching as a signal that the Legislature may be willing to treat different levels of the SUD care continuum differently: protecting against oversaturation in residential care while removing barriers to opioid treatment program capacity.

• HCR 50 — opioid abatement reporting in correctional facilities. Passed unanimously, this resolution requests state agencies report on opioid abatement and treatment programming inside Louisiana's correctional facilities and clarify available funding, an area where jail and prison populations remain underserved relative to need.

The bigger picture

Louisiana's SUD treatment landscape in mid-2026 is a state of genuine, quantifiable progress on reimbursement and access protections, sitting alongside slower movement on the parity enforcement and care-integration questions that increasingly define whether that access translates into actual treatment. The Legislature's willingness to differentiate its regulatory approach by level of care, protective for residential providers, deregulatory for opioid treatment programs, suggests policymakers are thinking about SUD care as a continuum rather than a single category. That's a useful frame for providers making the case for what comes next.

Sources: LATP membership data; the Louisiana Legislature; the Louisiana Department of Health; the Commonwealth Fund; AJMC; MoneyGeek; the Louisiana Illuminator.